Meiji Seika Pharma
Template:Short descriptionTemplate:Expand Japanese Script error: No such module "Unsubst". Script error: No such module "Infobox".Template:Template otherScript error: No such module "Check for conflicting parameters".Script error: No such module "Check for unknown parameters".
Script error: No such module "Nihongo"., formerly Script error: No such module "Nihongo". is a Japanese pharmaceutical company. It is currently a subsidiary of Meiji Holdings[1] and a Japanese leader in the area of infectious disease with 18% market share. It markets treatments for depression, obsessive-compulsive disorder, vaccines and allergy drugs. Meiji Pharma is doing research in generic anticancer drugs and biosimilars with partner organisations.[2]
They acquired the Stauffer Biscuit Company based in York, Pennsylvania, US, in 2004.[3]
On April 1, 2009, Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation established a joint holding company, Meiji Holdings, which is a constituent of the Nikkei 225 index. Two years later on the day, the food and healthcare business was taken over by Meiji Dairies to form "Meiji Co., Ltd.", and Meiji Seika was reorganized to a pharmaceutical company "Meiji Seika Pharma Co., Ltd."Script error: No such module "Unsubst". In 2014 Meiji acquired Medreich for $290 million, an Indian company active in selling generic pharmaceuticals to Europe, Asia and Africa.[4]
Logos
-
Old Meiji Seika brand logo (used from 1955 until March 2009)
-
Current logo
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
External links
- Pages with script errors
- Pages with broken file links
- Pages using infobox company using trading name
- Japanese companies established in 1916
- Japanese brands
- Pharmaceutical companies based in Tokyo
- Pharmaceutical companies established in 1916
- 2004 mergers and acquisitions
- 2011 mergers and acquisitions
- Companies formerly listed on the Tokyo Stock Exchange
- Chūō, Tokyo